PATENT CLAIM ANALYSIS

Application Number: 16181088
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["424", "136100"]

Abstract:
The present invention is in the fields of biochemistry, molecular biology, and Alzheimer's disease diagnosis, prevention, and treatment. Provided herein are humanized antibodies against human tau that are capable of discriminating between normal (healthy) and pathological (disease-associated) tau.

Claim (Index 197):
A method of evaluating a subject having, suspected of having, or being prone to have Alzheimer's Disease or another tauopathy, the method comprising the step of detecting binding of the composition according to  claim 180  to a component of a biological sample from the subject, wherein the detection of binding to the biological sample is indicative of Alzheimer's Disease or another tauopathy in the subject.

Metadata:
- Claim Count in Document: 79.0
- Percentile: 98.0
- Lexical Diversity: 1.28947
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15528333', '15342629', '15599685', '15906773', '15207836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7366696282221915
- 35 USC 102 Novelty (BERT): 0.6795069042810684
- Combined Prediction Score: 0.7309533558280792
- Mean Citation Score: 506.236552
- Max Citation Score: 786.5726
- Similarity Product: 651.6104911226869

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test